Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (261-270 of 306) with videos related to

Pageof 31
Sort By:
Hepatology (Baltimore, Md.)|January 20, 2011
Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevirFumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 22, 2018
Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitusNorio Akuta, Yusuke Kawamura, Chizuru Watanabe, et al.
Oncology|September 14, 2022
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based AnalysisNozomu Muraishi, Yusuke Kawamura, Norio Akuta, et al.
Cancers|August 12, 2023
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular CarcinomaYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Oncology|March 1, 2022
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular CarcinomaYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Internal Medicine (Tokyo, Japan)|October 18, 2019
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal LiverNobuhiko Ogasawara, Satoshi Saitoh, Hideyuki Denpou, et al.
Liver Cancer|August 20, 2025
First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 TrialMasatoshi Kudo, Masafumi Ikeda, Hiroshi Aikata, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 28, 2009
Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevirFumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 12, 2018
Primary liver carcinoma with sarcomatous changes: Analysis of 10 casesKazuki Ohya, Satoshi Saitoh, Shunichiro Fujiyama, et al.
Clinical Journal of Gastroenterology|January 11, 2021
An encapsulated bulky abdominal abscess due to amoebaSoichi Iritani, Yusuke Kawamura, Daiki Yamashige, et al.
Pageof 31

Showing results (261-270 of 306) with videos related to

Sort By:
Pageof 31
Hepatology (Baltimore, Md.)|January 20, 2011
Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevirFumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 22, 2018
Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitusNorio Akuta, Yusuke Kawamura, Chizuru Watanabe, et al.
Oncology|September 14, 2022
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based AnalysisNozomu Muraishi, Yusuke Kawamura, Norio Akuta, et al.
Cancers|August 12, 2023
Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular CarcinomaYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Oncology|March 1, 2022
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular CarcinomaYusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
Internal Medicine (Tokyo, Japan)|October 18, 2019
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal LiverNobuhiko Ogasawara, Satoshi Saitoh, Hideyuki Denpou, et al.
Liver Cancer|August 20, 2025
First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 TrialMasatoshi Kudo, Masafumi Ikeda, Hiroshi Aikata, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 28, 2009
Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevirFumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 12, 2018
Primary liver carcinoma with sarcomatous changes: Analysis of 10 casesKazuki Ohya, Satoshi Saitoh, Shunichiro Fujiyama, et al.
Clinical Journal of Gastroenterology|January 11, 2021
An encapsulated bulky abdominal abscess due to amoebaSoichi Iritani, Yusuke Kawamura, Daiki Yamashige, et al.
Pageof 31